NCT06895590

Brief Summary

The purpose of this study is to compare measurements of blood pressure (BP) and fluid responsiveness between the Philips AMC and invasive radial arterial line in surgical patients.

Trial Health

60
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
205

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Oct 2025

Shorter than P25 for all trials

Geographic Reach
2 countries

4 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 19, 2025

Completed
7 days until next milestone

First Posted

Study publicly available on registry

March 26, 2025

Completed
6 months until next milestone

Study Start

First participant enrolled

October 2, 2025

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2026

Completed
Last Updated

February 27, 2026

Status Verified

February 1, 2026

Enrollment Period

4 months

First QC Date

March 19, 2025

Last Update Submit

February 24, 2026

Conditions

Keywords

BP, FR, DBP, MAP, SBP, A-line

Outcome Measures

Primary Outcomes (1)

  • Primary Endpoints

    The comparison of systolic blood pressure (SBP), diastolic blood pressure (DBP), and mean arterial pressure (MAP) between the Philips AMC and radial arterial line.

    Approximately 8 months accrual and follow-up evaluation period.

Study Arms (1)

Philips AMC Cuff

This is a non-randomized, single arm, self-controlled observational study. The Philips AMC cuff will be tested on all enrolled participants.

Device: Philips Advanced Monitoring Cuff (i.e. AMC)

Interventions

Investigational, non-invasive upper arm cuff

Philips AMC Cuff

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Up to 205 non-cardiac surgical or Intensive Care Unit (ICU) patients being monitored with a radial arterial line will be enrolled over approximately 8 months accrual and follow-up evaluation period.

You may qualify if:

  • Adults aged 18 years and older
  • Indication for NIBP cuff
  • Indication for a radial arterial line
  • Subject or legal authorized representative is able to understand and speak the local language (also Spanish for US sites) to provide voluntary written informed consent prior to study procedures
  • The following stratification criteria must be met across the study sites and hence targeted enrollment may be required:
  • Age of every patient 18+; at least 30% \> 65 years, 30% ≤ 65 years
  • At least 30% male, 30% female
  • Minimum number of subjects needed to test each size cuff (per ISO81060-2:2018/AMD2:2024, based on limb circumference range):
  • Adult Small (19-27 cm) = 165\*\[8/(2\*24)\] = 28
  • Adult (25-34 cm) = 165\*\[9/(2\*24)\] = 31
  • Adult Large Short (30-40 cm with severely conical arm) = 165\*\[10/(2\*24)\] = 35
  • Adult Large (32-43 cm) = 165\*\[11/(2\*24)\] = 38
  • At least 40% of the subjects within each cuff size shall have a limb circumference that lies within the upper half of the specified range of use of the cuff
  • At least 40% of the subjects within each cuff size shall have a limb circumference within the lower half of the specified range of use of the cuff
  • At least 10% SBP measurements ≤ 100 mmHg
  • +3 more criteria

You may not qualify if:

  • Emergency surgery
  • Surgeries in which both arms are tucked
  • Inability to place the Philips AMC appropriately due to subject anatomy or condition
  • Known pregnancy or lactating women (self-report)
  • Patients treated with an intra-aortic balloon pump
  • Aortic and mitral regurgitation (\> 2nd degree), if known
  • Measurements taken in the lateral position
  • Pressure of the arterial line system, when tested at 100 mmHg with the VeriCal device, exceeds the +/- 2 mmHg threshold
  • Currently participating in an investigational drug or another device study that clinically interferes with the study endpoints
  • Upper arm circumference \< 19 cm or \> 43 cm
  • BMI \> 45
  • If the average of 3 baseline NIBP lateral difference measurements for SBP is \> 15 mmHg or for DBP is \> 10 mmHg
  • At the PI's discretion, subject does not qualify to participate in the study for any reasons that are not mentioned above

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

Beth Israel Deaconess Medical Center

Boston, Massachusetts, 02215, United States

RECRUITING

Duke University Health System

Durham, North Carolina, 27710, United States

RECRUITING

Wake Forest Baptist Medical Center

Winston-Salem, North Carolina, 27157, United States

RECRUITING

LMU Klinikum , Campus Großhadern

München, Bavaria, 81377, Germany

RECRUITING

Central Study Contacts

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 19, 2025

First Posted

March 26, 2025

Study Start

October 2, 2025

Primary Completion

February 1, 2026

Study Completion

February 1, 2026

Last Updated

February 27, 2026

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will not share

Locations